CClinicalTrials.gg
CompletedNCT03272178Updated Dec 1, 2021

Impact of Component Design and Fixation in Total Knee Arthroplasty

An observational study in Arthroplasties, Knee Replacement, sponsored by Washington University School of Medicine. Completed at 1 site in United States. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2021-12-01.

Sponsored by Washington University School of Medicine · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
100
Ages
18 Years to 75 Years
Sex
All
01

Study summary

The purpose of this study is to determine implant design and determine if method of fixation cemented versus cementless results in different bone loss patterns. The investigators also want to determine if clinical outcomes correlate with bone density changes.

Read the detailed description

Patients who present to the clinical practices of Dr. Ryan Nunley and Dr. Robert Barrack and are suitable candidates for primary total knee arthroplasty(TKA) type assigned either cemented or cementless and Triathlon knee or Depuy by surgeon will be screened for eligibility and invited to participate. Data collected for the study will include standard of care clinical and radiographic evaluations collected during office visits and surgery, Dual Energy X-Ray Absorptiometry(DEXA) Bone density monitoring, as well as study-specific patient questionnaires. Clinical, radiographic and questionnaire data will be collected pre-operatively, at the time of surgery, and at 6 weeks, 1 year and beyond, and 2 years and beyond post-operatively. Patients will complete the following outcomes questionnaires preoperatively: New Knee Society Score, Oxford Knee Score, UCLA Activity Score, SF-12, and EQ-5D. The following questionnaires will be collected at four to six weeks, six months, one year and beyond, and two years and beyond postoperatively: New Knee Society Score, Forgotten Joint Score, Washington University Knee Satisfaction and Function Questionnaire, Oxford Knee Score, UCLA Activity Score, SF-12, and EQ-5D, and a Pain Drawing.

02

Conditions studied

  • Arthroplasties, Knee Replacement
03

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

A. Patients who qualify for a Primary Total Knee Arthroplasty using Stryker Triathlon Implant(thin tray) or Depuy Attune(thick tray) Implant

Inclusion criteria

  • Patients who qualify for a Primary Total knee using Triathlon Implant(thin tray) or Depuy Attune(thick tray) Implant
  • 18-75 years of age
  • Willing to sign informed consent
  • Willing to return for all follow-up visits

Exclusion criteria

Exclusion Criteria:

  • Patients with inflammatory arthritis
  • BMI > 40
  • Patient with an active infection or suspected infection in the joint
  • Patient who have undergone osteotomy
  • Patients who have a previous diagnosis of osteopenia/osteoporosis or patients with weak bones and/or currently on medications to increase bone density/who have poor bone quality
  • Patients who have had previous patella fracture or surgery
  • Patients who have had previous knee or hip replacement surgery on the ipsilateral side
  • Patients who require patellar resurfacing
  • Patient with major medical/muscular/orthopedic deformities
  • Unable to undergo DEXA scanning.
  • Female patients of childbearing potential and an interest in getting pregnant in the future *NOTE: Patients receiving simultaneous bilateral total knee arthroplasties are eligible. Both knees are eligible for enrollment as long as all other inclusion/exclusion criteria are met for each knee. If only one knee is eligible it will be included. Patients receiving staged bilaterals are also eligible, provided that each knee meets the inclusion exclusion criteria.
04

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
100 participants (actual)
Patient registry
No

Groups and cohorts

  • Triathlon knee total knee arthroplasty

    50 Patients who are assigned to Triathlon knee, half cemented/half cementless

    Device: Triathlon total knee implant

  • Depuy knee total knee arthroplasty

    50 Patients who are assigned to Depuy knee, half cemented/half cementless

    Device: Depuy total knee implant

Interventions

  • DeviceDepuy total knee implant

    patients from Dr Nunley's clinic will get a Depuy implant

  • DeviceTriathlon total knee implant

    patients from Dr Barrack's clinic will get a Triathlon implant

05

What researchers measure

Primary outcomes

  1. Change in bone density

    Patients will have a DEXA scan to look for change in bone loss at 6 weeks, 1 year, and 2 year to determine bone loss patterns and geometry

    Time frame: 2 years

Secondary outcomes

  1. knee society score

    Knee society score questionnaire will be completed preoperatively, 6 weeks, 1 year, and 2 year.

    Time frame: 2 years

  2. Forgotten joint score

    Forgotten join score questionnaire will be completed preoperatively, 6 weeks, 1 year, and 2 year.

    Time frame: 2 years

  3. Oxford knee score

    Oxford knee score questionnaire will be completed preoperatively, 6 weeks, 1 year, and 2 year.

    Time frame: 2 years

  4. UCLA Activity score

    UCLA questionnaire will be completed preoperatively, 6 weeks, 1 year, and 2 year.

    Time frame: 2 years

  5. SF-12

    SF-12 questionnaire will be completed preoperatively, 6 weeks, 1 year, and 2 year.

    Time frame: 2 years

  6. EQ-5D

    EQ-5D questionnaire will be completed preoperatively, 6 weeks, 1 year, and 2 year.

    Time frame: 2 years

06

Study locations

1 site
  • Washington University School of Medicine
    Saint Louis, Missouri 63110, United States
07

Registry details

Key details

Study ID
NCT03272178
Lead sponsor
Washington University School of Medicine
Collaborators
Stryker Nordic
Responsible party
Sponsor
First posted
Sep 5, 2017
Start date
Nov 20, 2017
Primary completion
Nov 15, 2021
Completion
Nov 15, 2021
Last update
Dec 1, 2021

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion